Correlation Between Iteos Therapeutics and Annexon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Iteos Therapeutics and Annexon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iteos Therapeutics and Annexon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iteos Therapeutics and Annexon, you can compare the effects of market volatilities on Iteos Therapeutics and Annexon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iteos Therapeutics with a short position of Annexon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iteos Therapeutics and Annexon.

Diversification Opportunities for Iteos Therapeutics and Annexon

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Iteos and Annexon is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Iteos Therapeutics and Annexon in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annexon and Iteos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iteos Therapeutics are associated (or correlated) with Annexon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annexon has no effect on the direction of Iteos Therapeutics i.e., Iteos Therapeutics and Annexon go up and down completely randomly.

Pair Corralation between Iteos Therapeutics and Annexon

Given the investment horizon of 90 days Iteos Therapeutics is expected to under-perform the Annexon. But the stock apears to be less risky and, when comparing its historical volatility, Iteos Therapeutics is 1.26 times less risky than Annexon. The stock trades about -0.19 of its potential returns per unit of risk. The Annexon is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest  614.00  in Annexon on August 28, 2024 and sell it today you would lose (85.00) from holding Annexon or give up 13.84% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Iteos Therapeutics  vs.  Annexon

 Performance 
       Timeline  
Iteos Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Iteos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Annexon 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Annexon has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Iteos Therapeutics and Annexon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Iteos Therapeutics and Annexon

The main advantage of trading using opposite Iteos Therapeutics and Annexon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iteos Therapeutics position performs unexpectedly, Annexon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annexon will offset losses from the drop in Annexon's long position.
The idea behind Iteos Therapeutics and Annexon pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities